135 related articles for article (PubMed ID: 24233023)
1. Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling.
Kim MH; Jee JH; Park S; Lee MS; Kim KW; Lee MK
J Endocrinol; 2014 Feb; 220(2):117-28. PubMed ID: 24233023
[TBL] [Abstract][Full Text] [Related]
2. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
[TBL] [Abstract][Full Text] [Related]
3. Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides.
Liu C; Zhang M; Hu MY; Guo HF; Li J; Yu YL; Jin S; Wang XT; Liu L; Liu XD
J Endocrinol; 2013 May; 217(2):185-96. PubMed ID: 23444389
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell.
Mulherin AJ; Oh AH; Kim H; Grieco A; Lauffer LM; Brubaker PL
Endocrinology; 2011 Dec; 152(12):4610-9. PubMed ID: 21971158
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells.
Yi F; Sun J; Lim GE; Fantus IG; Brubaker PL; Jin T
Endocrinology; 2008 May; 149(5):2341-51. PubMed ID: 18258680
[TBL] [Abstract][Full Text] [Related]
6. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
7. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.
Qin Y; Chen M; Yang Y; Zhou XR; Shao SY; Wang DW; Yuan G
Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881
[TBL] [Abstract][Full Text] [Related]
9. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine.
Petersen N; Frimurer TM; Terndrup Pedersen M; Egerod KL; Wewer Albrechtsen NJ; Holst JJ; Grapin-Botton A; Jensen KB; Schwartz TW
Gastroenterology; 2018 Oct; 155(4):1164-1176.e2. PubMed ID: 29935151
[TBL] [Abstract][Full Text] [Related]
11. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells.
Kappe C; Holst JJ; Zhang Q; Sjöholm A
Biochem Biophys Res Commun; 2012 Oct; 427(1):91-5. PubMed ID: 22982676
[TBL] [Abstract][Full Text] [Related]
13. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
[TBL] [Abstract][Full Text] [Related]
14. P21-activated protein kinase 1 (Pak1) mediates the cross talk between insulin and β-catenin on proglucagon gene expression and its ablation affects glucose homeostasis in male C57BL/6 mice.
Chiang YA; Shao W; Xu XX; Chernoff J; Jin T
Endocrinology; 2013 Jan; 154(1):77-88. PubMed ID: 23183186
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
[TBL] [Abstract][Full Text] [Related]
16. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
[TBL] [Abstract][Full Text] [Related]
17. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
18. [D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice.
Novakovic ZM; Leinung MC; Grasso P
Peptides; 2013 May; 43():167-73. PubMed ID: 23500518
[TBL] [Abstract][Full Text] [Related]
19. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
Willard FS; Wootten D; Showalter AD; Savage EE; Ficorilli J; Farb TB; Bokvist K; Alsina-Fernandez J; Furness SG; Christopoulos A; Sexton PM; Sloop KW
Mol Pharmacol; 2012 Dec; 82(6):1066-73. PubMed ID: 22930710
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion.
Zhang H; Li J; Liang X; Luo Y; Zen K; Zhang CY
J Mol Endocrinol; 2012 Apr; 48(2):151-8. PubMed ID: 22257551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
